Michael A. Kelly Sells 1,062 Shares of Mettler-Toledo International Inc. (NYSE:MTD) Stock

Mettler-Toledo International Inc. (NYSE:MTD - Get Free Report) Director Michael A. Kelly sold 1,062 shares of the firm's stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director now owns 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Mettler-Toledo International Stock Performance

MTD stock traded down $16.85 during trading on Friday, hitting $1,156.33. 317,154 shares of the company's stock traded hands, compared to its average volume of 150,406. Mettler-Toledo International Inc. has a 52 week low of $946.69 and a 52 week high of $1,546.93. The stock has a market capitalization of $24.03 billion, a price-to-earnings ratio of 28.53, a P/E/G ratio of 3.30 and a beta of 1.40. The business has a fifty day simple moving average of $1,093.82 and a 200 day simple moving average of $1,205.75.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The company had revenue of $883.74 million during the quarter, compared to analyst estimates of $876.61 million. During the same quarter last year, the business posted $8.89 earnings per share. The firm's revenue was down 4.6% on a year-over-year basis. Research analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Mettler-Toledo International

A number of large investors have recently modified their holdings of the business. Acadian Asset Management LLC lifted its position in Mettler-Toledo International by 84.9% during the first quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier's stock valued at $2,965,000 after purchasing an additional 1,154 shares during the period. Geneos Wealth Management Inc. lifted its stake in shares of Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier's stock worth $78,000 after buying an additional 30 shares in the last quarter. Focus Partners Wealth increased its stake in shares of Mettler-Toledo International by 85.6% in the 1st quarter. Focus Partners Wealth now owns 3,195 shares of the medical instruments supplier's stock worth $3,774,000 after acquiring an additional 1,474 shares during the last quarter. Ransom Advisory Ltd acquired a new stake in Mettler-Toledo International during the first quarter worth $125,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Mettler-Toledo International by 42.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier's stock valued at $361,030,000 after acquiring an additional 90,395 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Analyst Upgrades and Downgrades

MTD has been the topic of several analyst reports. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price target for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research report on Monday, April 7th. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research report on Monday, May 5th. Finally, Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a report on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has an average rating of "Hold" and a consensus target price of $1,302.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.